Controlling complementary medicine claims

Australian Prescriber

Volumn 31, Issue 6, 2008, Pages 142-143

  Harvey, Ken J ^a  

^a NONE

Author keywords

Advertising; Drug industry; Drug regulation

Indexed keywords

GLUCOSAMINE; GLUCOSAMINE SULFATE; N ACETYLGLUCOSAMINE;

ALTERNATIVE MEDICINE; CLINICAL EFFECTIVENESS; EDITORIAL; GOVERNMENT; MEDICAL RESEARCH; TREATMENT INDICATION;

EID: 57349126242     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2008.079     Document Type: Editorial

References (7)

1. Harvey KJ, Korczak VS, Marron LJ, Newgreen DB. Commercialism, choice and consumer protection: regulation of complementary medicines in Australia. Med J Aust 2008;188:21-5.
2. Australian Self-Medication Industry. ASMI's position on the listing system. 2008 Jun 5. http://www.asmi.com.au/news/article.aspx?articleid=350 [cited 2008 Nov 10]
3. Complementary Healthcare Council of Australia. Complementary medicine regulation protects consumers [media release]. 2008 Jun 3. http://www.chc.org. au/view/document.shtml?v13023-jqrvdff [cited 2008 Nov 10]
4. eBS Australian Register of Therapeutic Goods. Current Medicines. https://www.ebs.tga.gov.au [cited 2008 Nov 10]
5. Oschmann R, Biber A, Lang F, Stumpf H, Kunz K. [Pharmacokinetics of beta-escin after administration of various Aesculus extract containing formulations]. Pharmazie 1996;51:577-81. German.
6. Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD002946. DOI: 10.1002/14651858. CD002946.pub2
7. Expert Committee on Complementary Medicines in the Health System. Complementary medicines in the Australian health system. Report to the Parliamentary Secretary to the Minister for Health and Ageing. Canberra: Commonwealth of Australia; 2003. http://www.tga.gov.au/docs/html/cmreport1.htm [cited 2008 Nov 10]